Tokyo-based Hoya Corp. said fiscal fourth-quarter profit rose 2.4% year over year while revenue rose 7.6%.
The Japanese healthcare supplies company's three-month profit attributable to owners of the company amounted to ¥19.37 billion, up from ¥18.92 billion in 2017.
Diluted EPS for the quarter was ¥50.90, up from ¥48.65 in the year-ago quarter.
Consolidated revenue for the three-month period ended March 31 came in at ¥135.92 billion, up from ¥126.30 billion the previous year.
Fourth-quarter research and development expenses were ¥5.91 billion, up from ¥5.70 billion in the year-ago period.
For the fiscal year ended March 31, Hoya said profit attributable to owners of the company was ¥99.49 billion, up 14.7% from ¥86.74 billion the previous year.
Diluted EPS was ¥257.88, up from ¥221.49 in the year-ago period.
Consolidated revenue for the 12-month period was ¥535.61 billion, up 11.8% from ¥478.93 billion in 2017. Research and development expenses for the full fiscal year reached ¥23.29 billion, up from ¥21.83 billion the previous year.
As of May 9, US$1 was equivalent to ¥109.74.